Key result
Tissue engineered heart valves are advancing toward clinical translation to address the major global mortality burden of valvular heart disease.
Key points are not available for this paper at this time.
Design
Review
Advances understanding of tissue-engineered heart valve development; leaves open clinical translation timelines.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Emmert et al. (2016) studied this question. Tissue engineered heart valves are advancing toward clinical translation to address the major global mortality burden of valvular heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: